Covered recipient · General Payments record
BILIKISU BHADMUS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,213.11
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $618.66 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $167.92 | 3 |
| E.R. Squibb & Sons, L.L.C. | $147.76 | 1 |
| GlaxoSmithKline, LLC. | $144.09 | 2 |
| GENZYME CORPORATION | $36.00 | 1 |
| Daiichi Sankyo Inc. | $29.72 | 1 |
| Acerta Pharma LLC | $26.29 | 1 |
| Genmab U.S., Inc. | $23.54 | 1 |
| Merck Sharp & Dohme Corporation | $22.05 | 1 |
| PFIZER INC. | $21.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $26.29 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105391922 | CMS |
| Daiichi Sankyo Inc. | $29.72 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089400019 | CMS |
| E.R. Squibb & Sons, L.L.C. | $147.76 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101703694 | CMS |
| Genmab U.S., Inc. | $23.54 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126834442 | CMS |
| GENZYME CORPORATION | $36.00 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139667286 | CMS |
| GlaxoSmithKline, LLC. | $19.27 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116497795 | CMS |
| GlaxoSmithKline, LLC. | $124.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116330674 | CMS |
| Janssen Biotech, Inc. | $18.75 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078471116 | CMS |
| Janssen Biotech, Inc. | $117.81 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078470893 | CMS |
| Janssen Biotech, Inc. | $31.36 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078471184 | CMS |
| Merck Sharp & Dohme LLC | $22.05 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141823451 | CMS |
| PFIZER INC. | $21.29 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131306050 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.